Cellular & Molecular Biology

Stanford Medicine researchers have created a molecule that blocks an enzyme thought to be instrumental in causing colon cancer relapse or chemotherapy resistance.

Stanford Medicine researchers and their collaborators have identified a molecule that staves off hunger post-exercise.

A new study has identified a way that the immune system shoots down its own cells when their anti-viral activity threatens to become friendly fire. The finding could pave the way to new treatments for autoimmune diseases.

In preliminary tests, SAMβA (pronounced “samba”) appears to improve heart functions in rats with heart failure caused by a heart attack.

To treat diabetes directly, rather than manage its symptoms, doctors need a way to get drugs to cells that produce insulin. The key, Stanford researchers report, may be those cells’ affinity for zinc.

In a cell, death is akin to falling dominoes: One death-inducing molecule activates another, and so on, until the entire cell is shut down, a new Stanford study finds.

Fanconi anemia is a rare but deadly disease thought to be the result of aldehyde-induced DNA damage. Now, Stanford researchers are developing a test that could help kids with the disease and millions more with related conditions.

A circadian code controls the switch that produces fat cells, according to a new study by Stanford researchers.

The Macromolecular Structure Knowledge Center can help researchers who lack equipment for testing hundreds of different crystallization conditions or expertise in working with challenging molecules.